Literature DB >> 33571845

Integrated analysis of multiple microarray studies to identify novel gene signatures in preeclampsia.

Qingling Kang1, Wei Li1, Juan Xiao1, Nan Yu1, Lei Fan1, Menghan Sha1, Songyan Ma1, Jianli Wu1, Suhua Chen2.   

Abstract

INTRODUCTION: Preeclampsia (PE) is one of the major causes of maternal and fetal morbidity and mortality in pregnancy worldwide. However, the intrinsic molecular mechanisms underlying the pathogenesis of PE have not yet been fully elucidated.
METHODS: Robust rank aggregation (RRA), weighted correlation network analysis (WGCNA) and protein-protein interaction (PPI) methods were used to identify robust differentially expressed genes (DEGs) and hub genes in preeclampsia and subgroups based on 10 Gene Expression Omnibus (GEO) datasets. Subsequently, enrichment analysis and correlation analysis were performed to explore the potential function of the robust DEGs and hub genes. The diagnostic role of hub genes was further investigated by GSE12767. The miRNA regulators and the effect of hypoxia on hub genes were explored by using GSE84260 and GSE65271, respectively.
RESULTS: Robust DEGs were identified in each subgroup including preeclampsia. Totally, 24 hub genes enriched in inflammatory response, renin-angiotensin system and JAK-STAT pathway, and 24 related miRNA regulators were identified. DISCUSSION: Our integrated analysis identified novel gene signatures in preeclampsia and subgroups and will contribute to the understanding of comprehensive molecular changes in preeclampsia.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Differentially expressed genes; Integrated analysis; Microarray; Preeclampsia; Protein-protein interaction; Robust rank aggregation; Weighted correlation network analysis; miRNAs

Mesh:

Year:  2021        PMID: 33571845     DOI: 10.1016/j.placenta.2021.01.023

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

1.  Network-Based Analysis Reveals Novel Biomarkers in Peripheral Blood of Patients With Preeclampsia.

Authors:  Jing Lin; Yu Meng; Meng-Fan Song; Wei Gu
Journal:  Front Mol Biosci       Date:  2022-06-16

2.  ceRNA Network and Functional Enrichment Analysis of Preeclampsia by Weighted Gene Coexpression Network Analysis.

Authors:  Chenxu Wang; Chaofan Yang; Xinying Wang; Guanlun Zhou; Chao Chen; Guorong Han
Journal:  Comput Math Methods Med       Date:  2022-01-07       Impact factor: 2.238

3.  G-Protein Coupled Receptor Dysregulation May Play Roles in Severe Preeclampsia-A Weighted Gene Correlation Network Analysis of Placental Gene Expression Profile.

Authors:  Manuel S Vidal; Christian Deo T Deguit; Gracia Fe B Yu; Melissa D Amosco
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

4.  Investigation and Validation of Molecular Characteristics of Endometrium in Recurrent Miscarriage and Unexplained Infertility from a Transcriptomic Perspective.

Authors:  Yuxin Ran; Jie He; Ruixin Chen; Yan Qin; Zheng Liu; Yunqian Zhou; Nanlin Yin; Hongbo Qi; Wei Zhou
Journal:  Int J Med Sci       Date:  2022-03-06       Impact factor: 3.738

5.  Identification and Verification of Potential Hub Genes in Amphetamine-Type Stimulant (ATS) and Opioid Dependence by Bioinformatic Analysis.

Authors:  Wei Zhang; Xiaodong Deng; Huan Liu; Jianlin Ke; Mingliang Xiang; Ying Ma; Lixia Zhang; Ming Yang; Yun Liu; Feijun Huang
Journal:  Front Genet       Date:  2022-03-30       Impact factor: 4.599

Review 6.  Differences in epidemiology of patients with preeclampsia between China and the US (Review).

Authors:  Ping Shi; Lei Zhao; Sha Yu; Jun Zhou; Jing Li; Ning Zhang; Baoxiang Xing; Xuena Cui; Shengmei Yang
Journal:  Exp Ther Med       Date:  2021-07-15       Impact factor: 2.447

7.  Identification of Hub Genes Associated with the Pathogenesis of Intracranial Aneurysm via Integrated Bioinformatics Analysis.

Authors:  Aifang Zhong; Ning Ding; Yang Zhou; Guifang Yang; Zhenyu Peng; Hongliang Zhang; Xiangping Chai
Journal:  Int J Gen Med       Date:  2021-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.